Resveratrol Protects Vascular Endothelial Cells from High Glucose–Induced Apoptosis through Inhibition of NADPH Oxidase Activation–Driven Oxidative Stress. (3rd June 2013)
- Record Type:
- Journal Article
- Title:
- Resveratrol Protects Vascular Endothelial Cells from High Glucose–Induced Apoptosis through Inhibition of NADPH Oxidase Activation–Driven Oxidative Stress. (3rd June 2013)
- Main Title:
- Resveratrol Protects Vascular Endothelial Cells from High Glucose–Induced Apoptosis through Inhibition of NADPH Oxidase Activation–Driven Oxidative Stress
- Authors:
- Chen, Feng
Qian, Li‐Hua
Deng, Bo
Liu, Zhi‐Min
Zhao, Ying
Le, Ying‐Ying - Abstract:
- <abstract abstract-type="main" id="cns12131-abs-0001"> <title>Summary</title> <sec id="cns12131-sec-0001" sec-type="section"> <title>Introduction</title> <p>Hyperglycemia‐induced oxidative stress has been implicated in diabetic vascular complications in which NADPH oxidase is a major source of reactive oxygen species (ROS) generation. Resveratrol is a naturally occurring polyphenol, which has vasoprotective effects in diabetic animal models and inhibits high glucose (HG)–induced oxidative stress in endothelial cells.</p> </sec> <sec id="cns12131-sec-0002" sec-type="section"> <title>Aims</title> <p>We aimed to examine whether HG‐induced NADPH oxidase activation and ROS production contribute to glucotoxicity to endothelial cells and the effect of resveratrol on glucotoxicity.</p> </sec> <sec id="cns12131-sec-0003" sec-type="section"> <title>Results</title> <p>Using a murine brain microvascular endothelial cell line bEnd3, we found that NADPH oxidase inhibitor (apocynin) and resveratrol both inhibited HG‐induced endothelial cell apoptosis. HG‐induced elevation of NADPH oxidase activity and production of ROS were inhibited by apocynin, suggesting that HG induces endothelial cell apoptosis through NADPH oxidase–mediated ROS production. Mechanistic studies revealed that HG upregulated NADPH oxidase subunit Nox1 but not Nox2, Nox4, and p22<sup>phox</sup> expression through NF‐κB activation, which resulted in elevation of NADPH oxidase activity and consequent ROS production.<abstract abstract-type="main" id="cns12131-abs-0001"> <title>Summary</title> <sec id="cns12131-sec-0001" sec-type="section"> <title>Introduction</title> <p>Hyperglycemia‐induced oxidative stress has been implicated in diabetic vascular complications in which NADPH oxidase is a major source of reactive oxygen species (ROS) generation. Resveratrol is a naturally occurring polyphenol, which has vasoprotective effects in diabetic animal models and inhibits high glucose (HG)–induced oxidative stress in endothelial cells.</p> </sec> <sec id="cns12131-sec-0002" sec-type="section"> <title>Aims</title> <p>We aimed to examine whether HG‐induced NADPH oxidase activation and ROS production contribute to glucotoxicity to endothelial cells and the effect of resveratrol on glucotoxicity.</p> </sec> <sec id="cns12131-sec-0003" sec-type="section"> <title>Results</title> <p>Using a murine brain microvascular endothelial cell line bEnd3, we found that NADPH oxidase inhibitor (apocynin) and resveratrol both inhibited HG‐induced endothelial cell apoptosis. HG‐induced elevation of NADPH oxidase activity and production of ROS were inhibited by apocynin, suggesting that HG induces endothelial cell apoptosis through NADPH oxidase–mediated ROS production. Mechanistic studies revealed that HG upregulated NADPH oxidase subunit Nox1 but not Nox2, Nox4, and p22<sup>phox</sup> expression through NF‐κB activation, which resulted in elevation of NADPH oxidase activity and consequent ROS production. Resveratrol prevented HG‐induced endothelial cell apoptosis through inhibiting HG‐induced NF‐κB activation, NADPH oxidase activity elevation, and ROS production.</p> </sec> <sec id="cns12131-sec-0004" sec-type="section"> <title>Conclusions</title> <p>HG induces endothelial cell apoptosis through NF‐κB/NADPH oxidase/ROS pathway, which was inhibited by resveratrol. Our findings provide new potential therapeutic targets against brain vascular complications of diabetes.</p> </sec> </abstract> … (more)
- Is Part Of:
- CNS neuroscience & therapeutics. Volume 19:Number 9(2013)
- Journal:
- CNS neuroscience & therapeutics
- Issue:
- Volume 19:Number 9(2013)
- Issue Display:
- Volume 19, Issue 9 (2013)
- Year:
- 2013
- Volume:
- 19
- Issue:
- 9
- Issue Sort Value:
- 2013-0019-0009-0000
- Page Start:
- 675
- Page End:
- 681
- Publication Date:
- 2013-06-03
- Subjects:
- Neuropharmacology -- Periodicals
Central nervous system -- Diseases -- Effect of drugs on -- Periodicals
612.8 - Journal URLs:
- http://www.blackwell-synergy.com/loi/cnsnt ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cns.12131 ↗
- Languages:
- English
- ISSNs:
- 1755-5930
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.140000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4002.xml